Related Experiment Videos
Towards a vaccine against Ebola virus
Thomas W Geisbert1, Peter B Jahrling
1Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-5011, USA. tom.geisbert@amedd.army.mil
Expert Review of Vaccines
|January 9, 2004
Summary
Developing an Ebola virus vaccine is crucial due to bioterrorism concerns. This review examines historical vaccine development, current candidates, and commercialization strategies for an effective Ebola vaccine.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Ebola virus causes high-mortality hemorrhagic fever in humans and primates.
- No approved vaccines or therapies currently exist for human use.
- Past outbreaks were contained through quarantine, limiting commercial interest in vaccine development.
Purpose of the Study:
- To review historical efforts in developing an Ebola virus vaccine.
- To provide an overview of current Ebola vaccine candidates.
- To highlight strategies for successful commercial development of an Ebola vaccine.
Main Methods:
- Literature review of historical vaccine development attempts.
- Analysis of current Ebola vaccine candidates.
- Assessment of commercialization strategies for vaccine development.
Main Results:
- Heightened bioterrorism awareness has increased the perceived need for an Ebola vaccine.
- Several vaccine candidates are under investigation.
- Commercial development strategies are being explored to address market viability.
Conclusions:
- An effective Ebola virus vaccine is a growing priority.
- Current research focuses on diverse vaccine platforms and strategies.
- Addressing commercialization challenges is key to ensuring vaccine availability.